European Congress on Obesity 2024 - Satellite Symposium

Tuesday, 14 May 2024, VENICE, ITALY

Recording available now: Rhythm-sponsored Satellite Symposium at ECO 2024

Precision medicine in treating leptin melanocortin-4 receptor (MC4R) pathway diseases: addressing hyperphagia and early-onset severe obesity

KEY TOPICS:

  • Genetic impairments in the MC4R pathway and their role in hyperphagia and early-onset, severe obesity
  • Overview of MC4R pathway diseases, focusing on POMC, PCSK1 and LEPR deficiency
  • The role of precision medicine in the management of monogenic MC4R pathway disease
  • Overview of MC4R pathway diseases, focusing on Bardet-Biedl Syndrome (BBS)
  • The role of precision medicine in the management of BBS

Precision medicine in treating leptin melanocortin-4 receptor (MC4R) pathway diseases

Dr Metin Cetiner, MD, PhD

Please login or signup to unlock the videos

Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.

LoginSignup

Precision medicine in treating leptin melanocortin-4 receptor (MC4R) pathway diseases: Addressing hyperphagia and early-onset, severe obesity

Prof Pietro Maffei

Please login or signup to unlock the videos

Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.

LoginSignup

Speakers:

Prof Pietro Maffei

(Italy)

Dr Metin Cetiner, MD, PhD

(Germany)

If you are interested in hearing more about future Rhythm sponsored events, click here to register your interest.


This meeting was organised and funded by Rhythm Pharmaceuticals and is intended for healthcare professionals only.